Dr. Mockler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1664 N Virginia Street
Pathology MS/0350
Reno, NV 89557
Education & Training
Stony Brook MedicineFellowship, Selective Pathology, 2013 - 2014- Stony Brook Medicine/University HospitalResidency, Pathology-Anatomic and Clinical, 2009 - 2013
Ross University School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2019 - 2025
NV State Medical License 2019 - 2025
NY State Medical License 2013 - 2022- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 36 citationsKeratin 17 is a sensitive and specific biomarker of urothelial neoplasia.Sruthi Babu, Daniel C. Mockler, Lucia Roa-Peña, Agnieszka Szygalowicz, Nam Woo Kim
Modern Pathology. 2019-05-01 - 31 citationsKeratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.Daniel C. Mockler, Luisa F. Escobar-Hoyos, Ali Akalin, Jamie L. Romeiser, A. Laurie Shroyer
American Journal of Clinical Pathology. 2017-09-01 - 25 citationsLoss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression.Elizabeth R. Snedecor, Clifford C. Sung, Alejandra Moncayo, Brooke E Rothstein, Daniel C. Mockler
The Journal of Investigative Dermatology. 2015-05-01
Journal Articles
- Keratin 17 Is a Sensitive and Specific Biomarker of Urothelial NeoplasiaDaniel C Mockler, Shahram S Gholami, Kenneth R Shroyer, Richard Moffitt, Nam W Kim, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
